[HTML] sciencedirect.com

[HTML][HTML] Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD

X Chen, X Zheng, N Lu, R Zhang, W Zhai, Q Ma… - International …, 2023 - Elsevier
Objective Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a
serious life-threatening complication. The granulocyte colony-stimulated factor mobilized …
相关文章

Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD

X Chen, X Zheng, N Lu, R Zhang, W Zhai… - International … - pubmed.ncbi.nlm.nih.gov
Objective Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a
serious life-threatening complication. The granulocyte colony-stimulated factor mobilized …

Explorations of post-gDLI low-dose cyclophosphamide for preventing severe aGVHD.

X Chen, X Zheng, N Lu, R Zhang, W Zhai… - International …, 2023 - europepmc.org
Objective Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a
serious life-threatening complication. The granulocyte colony-stimulated factor mobilized …

EXPLORATIONS OF POST-GDLI LOW-DOSE CYCLOPHOSPHAMIDE FOR PREVENTING SEVERE AGVHD

X Zheng, X Chen, E Jiang - postersessiononline.eu
AKNOWLEDGEMENTS INTRODUCTION AIM METHOD ACKNOWLEDGEMENTS
CONCLUSIONS CONTACT INFORMATION RESULTS Page 1 ASH2023 Relapse after …